This company has been marked as potentially delisted and may not be actively trading. Innovate Biopharmaceuticals (INNT) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock INNT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period 1Elevan Biopharmaceuticals, Inc. Announces the Development of Its Next-Generation Peptide Therapeutics Headquarters in Fishers, IndianaJune 17, 2025 | finance.yahoo.comVascarta Receives FDA Orphan Drug Designation for Vasceptor® in the Treatment of Sickle Cell DiseaseJune 12, 2025 | tmcnet.comTagomics awarded £860 k Innovate UK Biomedical Catalyst grant for detection of colorectal cancerJune 10, 2025 | msn.comContext Therapeutics Names Dr. Karen Smith as Interim Chief Medical OfficerMay 10, 2025 | msn.comInnovent Biologics: Innovent Announces 2024 Annual Results and Business UpdatesMarch 26, 2025 | finanznachrichten.deLirum Therapeutics Announces Debut of LX-101 Results in Thyroid Eye Disease, Selected for Presentation at the 2025 NANOS Annual MeetingMarch 19, 2025 | markets.businessinsider.comMumbai Biocluster: Biologics Conference 2025 Concludes Successfully, Setting New Benchmarks in Biopharmaceutical Innovation and CollaborationFebruary 14, 2025 | finanznachrichten.deImmuneOnco Biopharmaceuticals Advances Cancer Treatment with New Clinical Trial of IMM2510January 14, 2025 | msn.comiTeos to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 8, 2025 | markets.businessinsider.comInnovationRx: Positive Clinical Trial Results For Generative AI-Designed DrugNovember 13, 2024 | forbes.comGilead's Stock Surge: What's Fueling the Momentum?November 8, 2024 | msn.comCRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation ConferenceNovember 8, 2024 | markets.businessinsider.comPfizer Inc. Reports Strong Q3 2024 Results, Raises GuidanceOctober 30, 2024 | msn.comInozyme Pharma Inc.: Inozyme Pharma Announces Positive Interim Data from Phase 1 SEAPORT 1 Trial of INZ-701October 27, 2024 | finanznachrichten.de6 Launch Challenges Biopharmaceutical Companies Face (And Possible Solutions)October 23, 2024 | forbes.comStrategic Partnership Between Matica Bio and Mongoose Bio to Accelerate TCR-T Cell Therapy DevelopmentOctober 16, 2024 | businesswire.com3 Biotech Stocks Set to Revolutionize MedicineOctober 15, 2024 | stocknews.comImpact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and AffiliatesOctober 7, 2024 | markets.businessinsider.comCherry Bekaert CEO Michelle Thompson Joins Board of Managers for The Innovate FundOctober 3, 2024 | finance.yahoo.comBuy Rating Issued for Context Therapeutics on CT-202’s Innovative TCE Approach and Market PotentialSeptember 24, 2024 | markets.businessinsider.comImpact BioMedical Inc. Introduces Leadership Team to Drive Innovation and GrowthSeptember 23, 2024 | tmcnet.comFMR LLC Acquires New Stake in Bicara Therapeutics IncSeptember 20, 2024 | finance.yahoo.comOrbiMed Advisors LLC Acquires New Stake in MBX Biosciences IncSeptember 18, 2024 | finance.yahoo.comONL Therapeutics Closes $65 Million in Oversubscribed Series D FinancingSeptember 13, 2024 | markets.businessinsider.comRedefining Patent Valuation In The Era Of Rapid Technological InnovationSeptember 4, 2024 | forbes.comGilead Sciences: Innovative Approaches to Healthcare Can Remove BarriersSeptember 4, 2024 | finance.yahoo.comCircle Pharma Closes $90 Million Series D Financing to Advance Innovative Oral Macrocycle TherapiesSeptember 3, 2024 | venturebeat.comVOp-Ed: AI-powered innovation and executives driving new era of biotechAugust 29, 2024 | msn.comCARISMA Therapeutics Inc (W2J.SG)August 24, 2024 | uk.finance.yahoo.comCARISMA THERAPEUTICS INC. (W2J.DU)August 24, 2024 | uk.finance.yahoo.comDirector Richard Scheller Sells 44,250 Shares of Alector Inc (ALEC)August 24, 2024 | nz.finance.yahoo.comInsider Sale at Catalyst Pharmaceuticals Inc (CPRX): Chief Operating & Scientific Officer ...August 23, 2024 | finance.yahoo.comTinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX), Appili Therapeutics (TSX: APLI) (OTC: APLIF) Enter Third Amending AgreementAugust 22, 2024 | msn.comBuy Rating Affirmed on Janux Therapeutics Inc. Amidst Promising Prostate Cancer Program Developments and Unique Bispecific PlatformAugust 14, 2024 | markets.businessinsider.comEsperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | insidermonkey.comEyenovia’s Strategic Collaborations and Innovative Optejet System Underpin Buy RatingAugust 14, 2024 | markets.businessinsider.comPulmatrix Inc.: Pulmatrix Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 14, 2024 | finanznachrichten.deAzitra, Inc. Announces Q2 2024 Financial Results and Provides Business UpdatesAugust 12, 2024 | finance.yahoo.comEdesa Biotech, Inc.: Edesa Biotech Reports Fiscal 3rd Quarter 2024 ResultsAugust 11, 2024 | finanznachrichten.deWerewolf Therapeutics, Inc.: Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 8, 2024 | finanznachrichten.deMacroGenics, Inc.: MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial ResultsAugust 8, 2024 | finanznachrichten.deAnalysts Expect ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) To Breakeven SoonAugust 3, 2024 | finance.yahoo.comMacroGenics, Inc.: MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with IncyteJuly 31, 2024 | finanznachrichten.deinPhronesis Announces Name Change to inThought LabsJuly 30, 2024 | tmcnet.comRosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses to Contact the Firm for Information About Their RightsJuly 29, 2024 | tmcnet.comImmix Biopharma, Inc.: California Institute for Regenerative Medicine Awards Funding for CAR-T NXC-201 U.S. AL Amyloidosis Clinical Trial (NEXICART-2)July 26, 2024 | finanznachrichten.deGilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and PipelineJuly 26, 2024 | uk.finance.yahoo.comIPIX Innovation Pharmaceuticals Inc.July 25, 2024 | seekingalpha.comVaxcyte, Inc. (5VA.F)July 25, 2024 | nz.finance.yahoo.comBuy Rating Affirmed: Clearside Biomedical’s Innovative Drug Delivery and Promising Clinical TrialsJuly 25, 2024 | markets.businessinsider.com Get Innovate Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INNT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INNT Media Mentions By Week INNT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INNT News Sentiment▼0.001.11▲Average Medical News Sentiment INNT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INNT Articles This Week▼00▲INNT Articles Average Week Get the Latest News and Ratings for INNT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Innovate Biopharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies SYRS News Today VRPX News Today NTHI News Today MENS News Today MOR News Today CALT News Today ZYME News Today MBX News Today AVTE News Today CYBN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INNT) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovate Biopharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovate Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
